Israeli Researchers Want ImClone To Pay Royalties
ImClone Systems Inc. should pay restitution and royalties and be required to get a license for its popular cancer drug Erbitux from the true inventors of the drug, an attorney for...To view the full article, register now.
Already a subscriber? Click here to view full article